IP Library › Granted Patent US 12,620,490
Granted Patent B2
US 12,620,490 · App. 17/704,531 · Granted May 5, 2026

System and method for detecting recurrence of a disease

Inventors: Soumya Ghose (Niskayuna, NY); Fiona Ginty (Saratoga Springs, NY); Cynthia Elizabeth Landberg Davis (Niskayuna, NY); Sanghee Cho (Niskayuna, NY); Sunil S. Badve (Indianapolis, IN); Yesim Gokmen-Polar (Noblesville, IN)
Assignees: GE Precision Healthcare LLC; The Trustees of Indiana University
G16H50/30G06T7/0012G06V10/26G16H30/40G06T2207/30096
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,620,490
App. No.
17/704,531
Granted
May 5, 2026
Kind
B2
Abstract

A method for determining a recurrence of a disease in a patient includes generating a medical image of an organ of the patient and then extracting an invasive edge around an area of interest in the medical image. A plurality of radiomics features is obtained from the invasive edge and the recurrence of the disease is determined based on the plurality of radiomics features.

Claims (35)

1 . A method for determining a recurrence of a disease in a patient, the method comprising:

generating a medical image of an organ of the patient;

extracting an invasive edge around an area of interest in the medical image;

obtaining a plurality of radiomics features from the invasive edge; and

determining the recurrence of the disease based on the plurality of radiomics features,

wherein the disease defines a breast cancer,

wherein determining the recurrence of the disease comprises:

ranking the plurality of radiomics features based on their ability to predict the recurrence of the cancer using a machine learning classifier; and

providing high ranking radiomics features to a deep neural network for classifying the medical image as a disease recurrent medical image or a disease non-recurrent medical image, and

wherein the deep neural network is trained on radiomics features that have been selected to predict the recurrence of the disease based on a plurality of training data pairs comprising noisy and pristine medical images.

2 . The method of claim 1 , wherein the medical image comprises an X-ray image, a computed tomography (CT) image, a magnetic resonance image (MRI) or an ultrasound image.

3 . The method of claim 1 , wherein the area of interest includes a tumor region.

4 . The method of claim 1 , wherein extracting the invasive edge comprises segmenting the area of interest from the medical image.

5 . The method of claim 4 , wherein the invasive edge includes an edge surrounding the area of interest having a width.

6 . The method of claim 5 , wherein the width of the invasive edge is dependent on the nature of the disease and a resolution of the medical image.

7 . The method of claim 5 , wherein the width of the invasive edge is in the range of 0.5 mm to 1 cm.

8 . The method of claim 1 , wherein the plurality of radiomics features comprises shape, texture, intensity, and gradient magnitude of the invasive edge.

9 . The method of claim 1 , wherein the disease comprises triple negative breast cancer, receptor positive breast cancer, or HER-2 positive breast cancer.

10 . The method of claim 1 further comprising extracting an area in the tumor region along with the invasive edge around the tumor region and determining the recurrence of the disease based on the radiomics features in both the invasive edge and the tumor region area.

11 . A system comprising:

a memory storing a machine learning model including a classifier and a deep learning network;

a display device; and

a processor communicably coupled to the memory and configured to:

receive a medical image of an organ of the patient;

rank a plurality of radiomics features based on their ability to predict the recurrence of the cancer using the classifier;

providing high ranking radiomics features of an invasive edge around an area of interest in the medical image to the deep learning network;

classify the medical image using the deep neural network as a disease recurrent image or a disease non-recurrent image based on the high ranking radiomics features; and

display the disease recurrent image via the display device,

wherein the disease defines a breast cancer, and

wherein the deep neural network is trained on radiomics features that have been selected to predict the recurrence of the disease based on a plurality of training data pairs comprising noisy and pristine medical images.

12 . The system of claim 11 , wherein the processor is further configured to extract the invasive edge by segmenting the area of interest from the medical image.

13 . The system of claim 11 , wherein the invasive edge includes an edge surrounding the area of interest having a width.

14 . The system of claim 13 , wherein the width of the invasive edge is in the range of 0.5 mm to 1 cm.

15 . The system of claim 11 , wherein the plurality of radiomics features comprises shape, texture, intensity, and gradient magnitude of the invasive edge.

16 . The system of claim 11 , wherein the disease comprises triple negative breast cancer, receptor positive breast cancer, or HER-2 positive breast cancer.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2022
From: GHOSE, SOUMYA; GINTY, FIONA; DAVIS, CYNTHIA ELIZABETH LANDBERG; CHO, SANGHEE
To: GE PRECISION HEALTHCARE LLC
Reel/Frame 059402/0569 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2022
From: BADVE, SUNIL S.; GOKMEN-POLAR, YESIM
To: THE TRUSTEES OF INDIANA UNIVERSITY
Reel/Frame 059402/0754 →
Continuity (1)
Related Publication 20230307137A1 · Sep 28, 2023
References Cited (32)
US 10380739B2 · Vega · 2019 [cited by applicant]
US 11721427B2 · Barnes · 2023 [cited by examiner]
US 11990241B2 · Yan · 2024 [cited by examiner]
US 20170193657A1 · Madabhushi · 2017 [cited by examiner]
US 20180247410A1 · Madabhushi · 2018 [cited by examiner]
US 20190087532A1 · Madabhushi · 2019 [cited by examiner]
US 20200234442A1 · Barnes · 2020 [cited by examiner]
US 20210233236A1 · Dogdas · 2021 [cited by examiner]
US 20220130084A1 · Litwiller · 2022 [cited by examiner]
US 20220261668A1 · Stumpe · 2022 [cited by examiner]
US 20230309836A1 · Ghose · 2023 [cited by examiner]
US 20230317293A1 · Cho · 2023 [cited by examiner]
CN 110400287 · 2021 [cited by examiner]
La Forgia, Daniele, et al. “Radiomic analysis in contrast-enhanced spectral mammography for predicting breast cancer histological outcome.” Diagnostics 10.9 (2020): 708. (Year: 2020). [cited by examiner]
Berthel et al, Detailed resolution analysis reveals spatial T cell heterogeneity in the invasive marginof colorectal cancer liver metastases associated with improved survival, Oncoimmunology2017, vol. 6, No. 3, e1286436… [cited by examiner]
Hendry et al, Assessing Tumor-infiltrating Lymphocytes in Solid Tumors, Advances in Anatomic Pathology ⋅ Aug. 2017 (Year: 2017). [cited by examiner]
Xu et al, Radiomic analysis of contrast-enhanced CT predictsmicrovascular invasion, Journal of Hepatology 2019 vol. 70 j 1133-1144 (Year: 2017). [cited by examiner]
Koelzer et al, The tumor border configuration of colorectal cancer, FrontiersinOncology | Gastrointestinal Cancers Feb. 2014 vol. 4 Article29 | 4 (Year: 2014). [cited by examiner]
Algohary et al., “Combination of Peri-Tumoral and Intra-Tumoral Radiomic Features on Bi-Parametric MRI Accurately Stratifies Prostate Cancer Risk: A Multi-Site Study.” Cancers vol. 12,8 2020, 13 pages. [cited by applicant]
Beig et al., “Perinodular and Intranodular Radiomic Features on Lung CT Images Distinguish Adenocarcinomas from Granulomas.” Radiology vol. 290,3 (2019): 783-792, 10 pages. [cited by applicant]
Braman et al., “Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer.” JAMA network open vol. 2,4 e192561. Apr. 5, 2019… [cited by applicant]
Braman et al., “Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.” Breast cancer research : BCR vol. 19,1 57. M… [cited by applicant]
Hendry et al., “Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1… [cited by applicant]
Prasanna et al., “Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.” Europea… [cited by applicant]
Bera Kaustav et al: “Predicting cancer outcomes with radiomics and artificial intelligence in radiology”, Nature Reviews Clinical Oncology, Nature, NY, US, vol. 19, No. 2, Oct. 18, 2021 (Oct. 18, 2021), pp. 132-146, XP0… [cited by applicant]
Chong Huan-Huan et al: “Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma= 5 cm”, European Radi… [cited by applicant]
EP application 23161412.4 filed Mar. 13, 2023—extended Search Report issued Aug. 14, 2023; 13 pages. [cited by applicant]
Groendahl A Rosvoll et al: “PO-0967 Prediction of treatment outcome for head and neck cancers using radiomics of PET/CT images”, Radiotherapy and Oncology, vol. 133, XP085697738. [cited by applicant]
Holbrook Matthew D. et al: “MRI-based radiomics of sarcomas in the preclinical arm of a co-clinical trial”, Medical Imaging 2020: Biomedical Applications in Molecular, Structural, and Functional Imaging, Feb. 28, 2020 (… [cited by applicant]
Lee S. et al: “1219P AI-powered prediction of 2-year relapse-free survival in operable NSCLC patients using beritumoral radiomic features according to tumour size in chest CT images”, Annals of Oncology, vol. 31, Sep. 1… [cited by applicant]
Mayerhoefer Marius E. et al: “Introduction to Radiomics”, The Journal of Nuclear Medicine, vol. 61, No. 4, Apr. 1, 2020 (Apr. 1, 2020), pp. 488-495, XP09307081 0. [cited by applicant]
Mouraviev Andrei et al: “Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgery”, NeuroOncology, vol. 22, No. 6, Jun. 9, 2020 (Jun. 9, 2020), pp. 797-805, XP093070802. [cited by applicant]